XENIOS AG – a Fresenius Medical Care company – unites two brands under one umbrella, Novalung and Medos. The Novalung and Medos products offer the full range of heart and lung support on one single platform: the Xenios console. This console enables next-generation therapies for heart and lung failure. No other company except XENIOS AG is offering minimally invasive heart and lung therapies on one single platform.
- the unique platform for two applications combining ICU (Novalung: iLA activve system platform), and OR (Medos: deltastream system)
- adapt the system to your needs
- increased safety through integrated emergency functions